Published in Antimicrob Agents Chemother on May 01, 1993
Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother (2000) 1.64
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Bacteremia caused by Arcobacter cryaerophilus 1B. J Clin Microbiol (1997) 1.59
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob Agents Chemother (2008) 1.15
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother (1996) 1.13
Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol (2003) 1.12
Resistance mechanisms in Campylobacter jejuni. Virulence (2013) 1.04
Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010-2011. Emerg Infect Dis (2013) 0.95
Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother (1998) 0.94
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother (2009) 0.85
Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli. J Clin Microbiol (1997) 0.82
Purulent pleurisy caused by Campylobacter lari. Eur J Clin Microbiol Infect Dis (1998) 0.82
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother (1991) 1.67
Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media. J Clin Microbiol (1985) 1.65
Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother (1985) 1.60
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother (1992) 1.57
Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother (1987) 1.34
Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother (1987) 1.27
Characterization of anaerobic gram-negative bacilli by using rapid slide tests for beta-lactamase production. J Clin Microbiol (1979) 1.23
Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics. Antimicrob Agents Chemother (1987) 1.12
Erythromycin resistance only found in Campylobacter coli. J Antimicrob Chemother (1983) 1.10
High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol (1997) 6.49
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Illicit use of methadone among i.v. drug users in Montreal. J Subst Abuse Treat (1995) 1.92
Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care (2003) 1.69
Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother (1991) 1.67
Survey of anaerobic susceptibility patterns in Canada. Antimicrob Agents Chemother (1986) 1.60
Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ (2001) 1.49
Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (1989) 1.48
Methodological validation and clinical usefulness of carbon-14-urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med (1997) 1.45
Evaluation of the Sensititre system for identification of Enterobacteriaceae. J Clin Microbiol (1983) 1.41
Infectious diseases as a subspecialty in Canada: status of the practice in Quebec. Rev Infect Dis (1991) 1.39
[Pneumococcal vaccine and the independently living elderly]. Union Med Can (1992) 1.39
Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis (2001) 1.37
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother (1984) 1.18
Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrob Agents Chemother (1992) 1.12
Campylobacter upsaliensis isolated from a breast abscess. J Clin Microbiol (1992) 1.10
Comparison of SmaI-defined genotypes of Campylobacter jejuni examined by KpnI: a population-based study. J Med Microbiol (2001) 1.09
Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada. Antimicrob Agents Chemother (1999) 1.06
Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility. Antimicrob Agents Chemother (1984) 1.01
Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (2001) 1.00
In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group. J Antimicrob Chemother (1986) 1.00
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother (2003) 0.99
Bacteremia caused by viridans streptococci in 71 children. Can Med Assoc J (1981) 0.99
Evaluation of the KOH test and the antibiotic disk test in routine clinical anaerobic bacteriology. J Clin Microbiol (1988) 0.98
Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers. Antimicrob Agents Chemother (1994) 0.96
Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis (1997) 0.95
Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metab Brain Dis (1991) 0.94
Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother (1998) 0.94
Disk diffusion susceptibility testing of the Bacteroides fragilis group. Antimicrob Agents Chemother (1987) 0.93
Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger. Am J Trop Med Hyg (1986) 0.92
Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS (2000) 0.91
Molecular strain typing of Campylobacter jejuni by pulsed-field gel electrophoresis in a single day. Can J Microbiol (2001) 0.88
Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group. Clin Infect Dis (1998) 0.88
Prevalence of vaginal schistosomiasis caused by Schistosoma haematobium in an endemic village in Niger. Trans R Soc Trop Med Hyg (1990) 0.87
Helicobacter pylori antibiotic resistance: trends over time. Can J Gastroenterol (2000) 0.87
Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989. Can J Public Health (1992) 0.86
[A case of hydatid cyst of the mediastinum in the Republic of Niger]. Med Trop (Mars) (1987) 0.86
Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase. Antimicrob Agents Chemother (1986) 0.85
Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparation. J Clin Microbiol (1984) 0.85
[Australia antigen in hepatitis: technical and clinical aspects]. Union Med Can (1971) 0.85
The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group. Can J Microbiol (1987) 0.84
Bacteroides fragilis resistant to both metronidazole and imipenem. J Antimicrob Chemother (1986) 0.84
Detection of surface and core antigens of hepatitis B virus in the liver of 164 human subjects. A study by immunoperoxidase and orcein staining. Gastroenterology (1976) 0.84
Detection of Australia antigen in liver biopsies by immunofluorescence. Can Med Assoc J (1973) 0.84
Hepatitis B antigen in Montréal blood donors: childhood institutionalization as an epidemiologic factor. Can Med Assoc J (1975) 0.84
Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Am J Trop Med Hyg (1995) 0.84
Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections. Clin Infect Dis (1997) 0.83
[Study of serum and secretory tracheo-bronchial immunoglobulins]. Union Med Can (1971) 0.83
Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination. Can Med Assoc J (1984) 0.83
Failure of trimethoprim/sulfamethoxazole in invasive Nocardia asteroides infection. Arch Intern Med (1979) 0.82
Ultrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel. Ann Soc Belg Med Trop (1989) 0.82
Hepatic abscess complicating ulceroglandular tularemia. Can Med Assoc J (1983) 0.81
[Extra-genital manifestations of gonorrhea]. Union Med Can (1973) 0.81
[Echography in urinary bilharziosis. Apropos of 304 studies in Niger]. Ann Radiol (Paris) (1988) 0.80
Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel. Trop Med Parasitol (1990) 0.80
Detection of hepatitis-B core antibody. Lancet (1976) 0.79
Appropriateness of extending the intensive phase of treatment based on smear results. Int J Tuberc Lung Dis (2004) 0.79
Letter: Antibodies against coat HBAg. Lancet (1974) 0.79
Leptospirosis: a diagnosis to be kept in mind. Can Dis Wkly Rep (1989) 0.79
A complication of BCG vaccine: A case of localized cutaneous abscess due to Mycobacterium bovis. Can J Infect Dis (1999) 0.79
Transmission of HIV-1 from seronegative but PCR-positive blood donor. Lancet (1992) 0.78
Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis. J Infect Dis (1999) 0.78
Thiamine deficiency in AIDS. Lancet (1991) 0.77
Usefulness of semi-quantitative cultures in the diagnosis of Clostridium difficile associated disease. Eur J Clin Microbiol Infect Dis (1991) 0.77
Dissemination of prostatic carcinoma: an autopsy study. J Natl Med Assoc (1986) 0.77
Risk factors for HIV seropositivity among people consulting for HIV antibody testing. CMAJ (1990) 0.75
Mixed infections with Hemophilus influenzae type b. Can Med Assoc J (1979) 0.75
Human herpesvirus 6 and chronic fatigue syndrome. Can J Infect Dis (1993) 0.75
[Empyema caused by anaerobic flora: clinical and microbiological study of 4 cases]. Union Med Can (1976) 0.75
[Extradural lipomatosis and sudden paraplegia. Recovery after laminectomy]. Rev Med Interne (1988) 0.75
[Inhibition by tuberculin of human leukocyte migration in agarose: correlation with skin reactivity]. Union Med Can (1976) 0.75
[Recurrence of a mycetoma due to Actinomadura madurae with visceral and lymph node involvement]. Ann Dermatol Venereol (1986) 0.75
[A case of icterohemorrhagic leptospirosis. The 6th Canadian case]. Union Med Can (1966) 0.75
[HB virus infection and delta surinfection in Sahelian Africa]. Rev Med Interne (1986) 0.75
[Infectious bacterial diarrhea: update and new agents]. Union Med Can (1984) 0.75
[Hydatid cyst of the thyroid. Apropos of a case in the Republic of Niger]. Bull Soc Pathol Exot Filiales (1988) 0.75
Non-O1 Vibrio cholerae enterocolitis in Quebec tourists returning from the Dominican Republic. Can Commun Dis Rep (1992) 0.75
[Chronic hepatitis, liver cirrhosis, primary liver cancer and virus HB infection. Epidemiologic study in a sahelian hospital milieu. Apropos of 185 cases]. Bull Soc Pathol Exot Filiales (1985) 0.75
Delta superinfection in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in a Sahelian area. Study of 112 cases versus 46 controls. Trans R Soc Trop Med Hyg (1987) 0.75
[Answer to April e-quid: pulmonary melioidosis: a symptomology of severe tuberculosis]. J Radiol (2008) 0.75
[Role of the hepatitis B virus in the origin of alcoholic liver disease]. Union Med Can (1974) 0.75
[Hepatic amebiasis at Niamey Hospital (Nigeria)]. Bull Soc Pathol Exot Filiales (1987) 0.75
[Site of synthesis of secretory IgA in the human respiratory tract]. Rev Can Biol (1973) 0.75
Update on Pan-American activities in the field of anaerobes: Canada. Clin Infect Dis (1997) 0.75
[Can bilharziasis be considered a health priority in western Africa, justifying control programs of large scope?]. Med Trop (Mars) (1995) 0.75
[Sensitivity of anaerobic bacteria to antibiotics: experience at Hôpital Saint-Luc]. Union Med Can (1984) 0.75
[2 cases of hydatidosis in the Republic of Niger]. Bull Soc Pathol Exot Filiales (1985) 0.75
[New cases of hydatidosis in Niger]. Bull Soc Pathol Exot Filiales (1985) 0.75
[Toxoplasmosis in Quebec. II. Retrospective serological study in pregnant women]. Union Med Can (1974) 0.75
[Detection of antibodies against mucleocapsids of hepatitis B virus (anti-HBc) by the immunoperoxidase inhibition technic: study of 225 subjects]. Union Med Can (1976) 0.75
[Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides]. Union Med Can (1984) 0.75